InTextoResearch, agence d'information scientifique
InTextoResearch vous informe sur les dernières parutions d'articles de
revue sur le cancer de l'ovaire (11 février 2008):
Management of relapsed/refractory epithelial ovarian cancer: current
standards and novel approaches.
Lin H, Changchien CC.
Taiwan J Obstet Gynecol. 2007 Dec;46(4):379-88.
Development of antiangiogenic agents for ovarian cancer.
Collinson FJ, Hall GD, Perren TJ, Jayson GC.
Expert Rev Anticancer Ther. 2008 Jan;8(1):21-32.
Cytoreductive surgery in ovarian cancer.
Pomel C, Jeyarajah A, Oram D, Shepherd J, Milliken D, Dauplat J,
Reynolds K.
Cancer Imaging. 2007 Dec 17;7:210-5.
Ovarian cancers in pregnancy.
Sessa C, Maur M.
Recent Results Cancer Res. 2008;178:75-8.
Endothelin receptor antagonists in cancer therapy.
Lalich M, McNeel DG, Wilding G, Liu G.
Cancer Invest. 2007 Dec;25(8):785-94.
Gynecologic tumors.
Reinhardt MJ.
Recent Results Cancer Res. 2008;170:141-50.
Non-random inactivation of large common fragile site genes in
different cancers.
McAvoy S, Ganapathiraju SC, Ducharme-Smith AL, Pritchett JR, Kosari F,
Perez DS, Zhu Y, James CD, Smith DI.
Cytogenet Genome Res. 2007;118(2-4):260-9.
The ovarian endothelin network: an evolving story.
Meidan R, Levy N.
Trends Endocrinol Metab. 2007 Dec;18(10):379-85.
The role of dendritic cells in cytotoxic immune response regulation in
ovarian cancer micro-environment.
Wertel I, Barczynski B, Kotarski J.
Front Biosci. 2008 Jan 1;13:2177-90.
Human endometrial and ovarian cancer cells: histone deacetylase
inhibitors exhibit antiproliferative activity, potently induce cell
cycle arrest, and stimulate apoptosis.
Takai N, Narahara H.
Curr Med Chem. 2007;14(24):2548-53.
Lymphoepithelioma-like carcinoma of the ovary: a case report and
review of the literature.
Lee S, Park SY, Hong EK, Ro JY.
Arch Pathol Lab Med. 2007 Nov;131(11):1715-8.
Treatment of peritoneal carcinomatosis from ovarian cancer. Present,
future directions and proposals.
Muñoz-Casares FC, Rufián S, Rubio MJ, Lizárraga E, Díaz-Iglesias C,
Aranda E, Ciria R, Muntané J, Barrios P, Torres-Melero J, González-
Moreno S, González-Bayón L, Camps B, Bretcha P, Farré J, Ortega-Pérez
G, Gómez-Portilla A.
Clin Transl Oncol. 2007 Oct;9(10):652-62.
New approach to cancer therapy: heparin binding-epidermal growth
factor-like growth factor as a novel targeting molecule.
Miyamoto S, Yagi H, Yotsumoto F, Horiuchi S, Yoshizato T,
Kawarabayashi T, Kuroki M, Mekada E.
Anticancer Res. 2007 Nov-Dec;27(6A):3713-21.
(contact pour InTextoResearch: Marc Lacroix, Baelen, Wallonie,
Belgique - scimedweb@mail.com)